Clinical Trials Sponsored by Naveris

Total 106 results

Northwell Health
Naveris

Recruiting

Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers

Cervical Cancer | Cervical Dysplasia

United States
University of Florida
Naveris, Inc.

Recruiting

Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma

Oropharyngeal Squamous Cell Carcinoma

United States
Aleris Obesity

Completed

Effects of Long Biliopancreatic Limb vs. Long Alimentary Limb in Superobesity, a Randomized Study

Weight Loss | Morbid Obesity

Sweden
Aleris Helse

Completed

Perioperative Hypothermia Hypothermia in Ambulatory Surgery

Perioperative/Postoperative Complications

Norway
Anteris Technologies Ltd.

Active, not recruiting

DurAVR™ THV System: First-In-Human Study

Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic Stenosis

Georgia
Vaderis Therapeutics AG

Recruiting

Assess Safety and Efficacy of VAD044 in HHT Patients

Hereditary Hemorrhagic Telangiectasia (HHT)

United States, Spain, France, Belgium, Netherlands, Italy
Anteris Technologies Ltd.

Active, not recruiting

Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study (DurAVR™ EFS)

Aortic Stenosis | Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic Stenosis

United States
Aleris Eye

Recruiting

Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods

Cataract

Sweden
Aleris Hospital

Active, not recruiting

Non-randomized Prospective Comparison Between SASI Bipartition and RYGB

Postoperative Complications | Metabolic Syndrome | Obesity, Morbid | Bariatric Surgery Candidate

Norway
Aversi Clinic

Unknown

Prestilol(Perindopril+Bisoprolol) in Therapy of Patients With Atrial Fibrilation

Patient Participation

Georgia
Aderis Pharmaceuticals

Completed

Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation

Atrial Fibrillation

United States
Jonathan Schoenfeld, MD, MPH
Naveris

Recruiting

Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study

HPV Positive Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC... and other conditions

United States
Aleris Helse
Novartis

Completed

A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO

Central Retinal Vein Occlusion | Macular Edema

Norway
Aeris Therapeutics

Terminated

A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema

Lung Diseases | Pulmonary Emphysema | Chronic Obstructive Pulmonary Disease(COPD)

Israel
Aeris Therapeutics

Terminated

Post Market Registry Study of the AeriSeal System

Pulmonary Emphysema

Germany, Israel
Aeris Therapeutics

Terminated

A Registry Study of the AeriSeal® System or Lung Volume Reduction in Patients With Advanced Emphysema

Emphysema | Chronic Pulmonary Obstructive Disease

Germany, Israel, Austria, France
Aeris Therapeutics

Completed

AeriSeal System for Lung Volume Reduction

Lung Diseases | Emphysema | Pulmonary Emphysema | Chronic Obstructive Pulmonary Disease (COPD)

Israel, Austria, France, Germany
Aeris Therapeutics

Completed

US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

Pulmonary Emphysema

United States
Aeris Therapeutics

Completed

A Dose Ranging Study of the Aeris Polymeric Lung Volume Reduction (PLVR) System in Patients With Advanced Upper Lobe Predominant Emphysema

Advanced Emphysema

Germany
Aeris Therapeutics

Terminated

Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation

Pulmonary Emphysema

Netherlands
Aeris Therapeutics

Terminated

Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation

Pulmonary Emphysema

Israel
Aeris Therapeutics

Completed

US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study

Pulmonary Emphysema

United States
Aeris Therapeutics

Terminated

Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant Emphysema (CV+/-)

Pulmonary Emphysema

Germany, Israel
Aeris Therapeutics

Withdrawn

Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema

Emphysema | Chronic Obstructive Pulmonary Disease (COPD)
Aeris Therapeutics

Completed

Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous Study

Homogeneous Emphysema

United States
Aeris Therapeutics

Completed

Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study

Chronic Obstructive Pulmonary Disease | Pulmonary Emphysema

Israel
Aeris Therapeutics

Withdrawn

Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema

Advanced Upper Lobe Predominant Emphysema
Aeris Therapeutics

Completed

US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation

Pulmonary Emphysema

United States
Memorial Sloan Kettering Cancer Center
Hookipa Biotech GmbH; Naveris

Recruiting

A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)

HPV16+ Squamous Cell Carcinoma

United States
Aeris Therapeutics

Terminated

Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE) (ASPIRE)

Pulmonary Emphysema

United States, Spain, France, Israel, Netherlands, Greece, Italy
Aeris Therapeutics

Completed

US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

Chronic Obstructive Pulmonary Disease | Pulmonary Emphysema

United States
Aeris Therapeutics

Completed

AeriSeal® System for Lung Volume Reduction in Patients With Advanced Emphysema

Lung Diseases | Pulmonary Emphysema | COPD

Israel
Aleris Obesity
Lund University

Unknown

Effects of Long Biliopancreatic Limb Versus Long Alimentary Limb in Superobesity, a Randomized Study (BMI>50)

Severe Obesity

Sweden
Yale University
Anteris Technologies Corporation

Recruiting

Defining Exercise Hemodynamics and Function After Transcatheter Aortic Valve Replacement (DEFINE-TAVR) Study. (DEFINE-TAVR)

Aortic Valve Stenosis

United States
Karsten Gavenis

Recruiting

A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3 (CABONEN)

Neuroendocrine Tumors | Neuroendocrine Carcinoma

Germany, Austria
Karolinska Institutet
Aleris Gastromottagningen City

Not yet recruiting

Effect of a Low- Fermentable-Oligo-Di- Monosaccharides and Polyols Diet Group Intervention on IBS Symptoms and Fatigue (FODMAPS)

Irritable Bowel Syndrome
Stemform
Aleris-Hamlet Hospitaler København

Completed

Cosmetic Fat Transplantation Using Expanded ASC Enriched Fat Grafts

Breast Hypoplasia and Facial Ageing

Denmark
United BioSource, LLC
AveXis, Inc.

Approved for marketing

AveXis Managed Access Program Cohort for Access to AVXS-101

Spinal Muscular Atrophy

United States
Fariba Nayeri

Unknown

Rapid Test for Detection of the Focus of Infection in Post Neurosurgical Patients.

Meningitis, Bacterial | Infection, Bacterial | Antibiotic Resistant Infection | Nosocomial Infection | Diagnostic Self Evaluation

Sweden
St. Olavs Hospital
Aleris Helse

Completed

Serum Concentration of Tranexamic Acid After Topical Administration in Massive Weight Loss Skin Reducing Surgery

Bleeding | Surgical Wound

Norway
Karsten Gavenis

Not yet recruiting

Validation of the TheraSure CNI Monitor Under Immune Checkpoint Therapy (Hereinafter: "Immunotherapy") in NSCLC in Palliative Therapy (CNI-Monitor)

NSCLC
AveXis, Inc.
United BioSource, LLC

Recruiting

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Spinal Muscular Atrophy (SMA)

Japan, United States, Korea, Republic of, Israel, Greece, Ireland, Portugal, Russian Federation, Taiwan
Azienda Ospedaliera Specializzata in Gastroenterologia...

Recruiting

Treatment of Perianal Fistulas in Crohn's Disease With Autologous Microfragmented Adipose Tissue With the Lipogems System

Fistula | Crohn Disease | Adipose Tissue

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Comparison of Anthropometric Parameters and Cardiometabolic Risk Factors Among Subjects With Overweight and Obesity

Obesity

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Unknown

Dysplasia in Inflammatory Chronic Idiopathic Colitis Long-standing

Dysplasia in IBD

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Unknown

Interactions Between Diet, Intestinal Microbiota and Metabolomics

Nutrition Disorders

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Glycemic Index of Traditional Egg Pasta

Healthy Subjects | Glycemic Response | Insulinemic Response

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Unknown

Diet and Physical Activity on NAFLD and Erytrocyte Membrane Lipid Profile.

NAFLD

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Effect of Physical Activity on NAFLD

NAFLD
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Effect of Low-Glycemic Index Mediterranean Diet on AGEs (Nutri_AGEs)

Obesity | Cardiovascular Disease | Insulin Resistance | Type 2 Diabetes

Italy

Clinical Trials Sponsored by Naveris

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations